Effects of Vitamin D3, Calcipotriol and FTY720 on the Expression of Surface Molecules and Cytolytic Activities of Human Natural Killer Cells and Dendritic Cells

In Vivo Regulation of Experimental Autoimmune Encephalomyelitis by NK Cells: Alteration of Primary Adaptive Responses

(2014) R. Winkler-Pickett et al.   JOURNAL OF IMMUNOLOGY

A One Year Follow-Up Study of Natural Killer and Dendritic Cells Activities in Multiple Sclerosis Patients Receiving Glatiramer Acetate (GA)

(2013) Rune A. Høglund et al.   PLoS One

Natural killer cells in HIV controller patients express an activated effector phenotype and do not up-regulate NKp44 on IL-2 stimulation

(2013) F. Marras et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

On The Role of Natural Killer Cells in Neurodegenerative Diseases

(2013) Azzam Maghazachi   Toxins

Natural killer cells and their receptors in multiple sclerosis

(2012) Gurman Kaur et al.   BRAIN

Stable antigen-specific T-cell hyporesponsiveness induced by tolerogenic dendritic cells from multiple sclerosis patients

(2012) Dàlia Raϊch-Regué et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Insights into NK cell biology from human genetics and disease associations

(2011) Stephanie M. Wood et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

1,25-Dihydroxyvitamin D3 enhances NK susceptibility of human melanoma cells via Hsp60-mediated FAS expression

(2011) Ji H. Lee et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Modulation of NK Cell Autocrine-Induced Eosinophil Chemotaxis by Interleukin-15 and Vitamin D3: A Possible NK-Eosinophil Crosstalk via IL-8 in the Pathophysiology of Allergic Rhinitis

(2011) A. E. El-Shazly et al.   MEDIATORS OF INFLAMMATION

Identification of Human NK17/NK1 Cells

(2011) Abhilash D. Pandya et al.   PLoS One

Dietary Vitamin D3 Supplements Reduce Demyelination in the Cuprizone Model

(2011) Stig Wergeland et al.   PLoS One

Vitamin D and multiple sclerosis

(2010) Alberto Ascherio et al.   LANCET NEUROLOGY

A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis

(2010) J. M. Burton et al.   NEUROLOGY

Safety and T Cell Modulating Effects of High Dose Vitamin D3 Supplementation in Multiple Sclerosis

(2010) Joost Smolders et al.   PLoS One

The Double-Edged Sword of Autoimmunity: Lessons from Multiple Sclerosis

(2010) Anne Lise K. Hestvik   Toxins

Regulation of human NK-cell cytokine and chemokine production by target cell recognition

(2009) C. Fauriat et al.   BLOOD

FTY720 and SEW2871 reverse the inhibitory effect of S1P on natural killer cell mediated lysis of K562 tumor cells and dendritic cells but not on cytokine release

(2009) Johannes Rolin et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Modulation of natural killer cell cytotoxicity and cytokine release by the drug glatiramer acetate

(2009) K. L. Sand et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Impact of vitamin D receptor activity on experimental autoimmune prostatitis

(2009) Ruben Darío Motrich et al.   JOURNAL OF AUTOIMMUNITY

Splenic natural killer cell activity in two models of experimental neurodegenerative diseases

(2009) Yassin Al-Falahi et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans

(2009) Cameron S. Brandt et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Oral fingolimod (FTY720) in multiple sclerosis: Two-year results of a phase II extension study

(2009) P. O'Connor et al.   NEUROLOGY

Vitamin D Status Is Positively Correlated with Regulatory T Cell Function in Patients with Multiple Sclerosis

(2009) Joost Smolders et al.   PLoS One

Dendritic Cells Release HLA-B-Associated Transcript-3 Positive Exosomes to Regulate Natural Killer Function

(2008) Venkateswara Rao Simhadri et al.   PLoS One